Therasense Inc
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision … Read more
Therasense Inc (THER) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 0.039x
Based on the latest financial reports, Therasense Inc (THER) has a cash flow conversion efficiency ratio of 0.039x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.50 Million) by net assets ($-38.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Therasense Inc - Cash Flow Conversion Efficiency Trend (2007–2023)
This chart illustrates how Therasense Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Therasense Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Therasense Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ALMIRALL (E2Z.SG)
STU:E2Z
|
0.029x |
|
Eco Innovation Group Inc
PINK:ECOX
|
0.000x |
|
VIVACON
BE:VIA
|
N/A |
|
Unieuro SpA
STU:1UI
|
-0.220x |
|
RAMSAY GENERALE (GD6.SG)
STU:GD6
|
N/A |
|
First Tidal Acquisition Corp.
V:AAA-P
|
-0.079x |
|
NORDIC SEMICONDUCTO
BE:N0S
|
0.024x |
|
ENERGY RECOVERY
BE:5E2
|
N/A |
Annual Cash Flow Conversion Efficiency for Therasense Inc (2007–2023)
The table below shows the annual cash flow conversion efficiency of Therasense Inc from 2007 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-09-30 | $-38.12 Million | $-5.77 Million | 0.152x | -89.31% |
| 2022-09-30 | $-3.80 Million | $-5.39 Million | 1.418x | -42.30% |
| 2021-09-30 | $-1.95 Million | $-4.78 Million | 2.458x | +219.84% |
| 2020-09-30 | $1.69 Million | $-3.47 Million | -2.051x | -2890.83% |
| 2019-09-30 | $-15.94 Million | $-1.17 Million | 0.073x | -52.57% |
| 2018-09-30 | $-14.81 Million | $-2.29 Million | 0.155x | -91.71% |
| 2017-09-30 | $-826.63K | $-1.54 Million | 1.868x | +221.78% |
| 2016-09-30 | $555.38K | $-851.84K | -1.534x | -150.91% |
| 2014-09-30 | $-138.82K | $-418.21K | 3.013x | +129.09% |
| 2013-09-30 | $61.56K | $-637.62K | -10.357x | -319.24% |
| 2012-09-30 | $245.37K | $-606.15K | -2.470x | -229.67% |
| 2011-09-30 | $984.00K | $-737.37K | -0.749x | -184.95% |
| 2010-09-30 | $-50.52K | $-44.56K | 0.882x | -89.02% |
| 2009-09-30 | $-6.71K | $-53.96K | 8.035x | +1075.93% |
| 2008-09-30 | $-56.11K | $-38.34K | 0.683x | -88.47% |
| 2007-09-30 | $-5.10K | $-30.21K | 5.928x | -- |